Riskpilot← Back to searchSign inGet full accessWiener Blut AB
ABActiveOrg 5591528848Mönstringsvägen 10Computer programming activities · NACE 6210Est. 20180 employees
Revenue 2025
SEK 287K
+551% vs 2024
EBITDA margin
92.1%
+1302% vs 2024
Equity ratio
76.7%
Financial strength
Net profit 2025
SEK 165K
+1146% vs 2024
| Revenue | SEK 287K | +551% |
| EBITDA | SEK 264K | +1302% |
| Net profit | SEK 165K | +1146% |
| Total assets | SEK 629K | +17% |
| Equity | SEK 483K | -7% |
| Employees | 0 | — |
Legal name
Wiener Blut AB
Org number
5591528848
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
19 mars 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva konsultverksamhet inom IT, programmering, medicinsk konsult- och utbildningsverksamhet inom hälso- och sjukvård, handel med värdepapper samt därmed förenlig verksamhet.
Address
Mönstringsvägen 10
Email
wienerblut@lefant.net
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | −0 | 44 | 287 |
| Staff expenses | — | — | — | −20 | 20 |
| EBITDA | −2 | −2 | −4 | 19 | 264 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −2 | −2 | −4 | 19 | 264 |
| Net financials | — | 0 | 1 | 1 | 0 |
| Profit before tax | −2 | −2 | −3 | 20 | 203 |
| Tax | −0 | — | — | −6 | −38 |
| Net profit | −2 | −2 | −3 | 13 | 165 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 509 | 507 | 504 | 540 | 629 |
| Equity | 509 | 507 | 504 | 517 | 483 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 0 | 0 | — | 3 | 86 |
| Total debt | — | — | — | 3 | 86 |
EBITDA margin
92.1%
This company
15.8%
Market median
+483% vs market
20212025
Equity ratio
76.7%
This company
38.2%
Market median
+101% vs market
20212025
Return on equity
34.3%
This company
18.4%
Market median
+86% vs market
20212025
Net profit margin
57.8%
This company
8.1%
Market median
+614% vs market
20212025
Asset turnover
0.46×
This company
1.12×
Market median
-59% vs market
20212025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
FL Chief Executive Officer | Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Wiener Blut AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mariam Amouzandeh | Deputy Chief Executive Officer | 0 companies |
| Fabian Linzberger | Chief Executive Officer | 0 companies |